MEDICAL MYOCARDIAL PROTECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING CORONARY ARTERY BYPASS GRAFTING

MEDICAL MYOCARDIAL PROTECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING CORONARY ARTERY BYPASS GRAFTING

In the study 76 patients with acute coronary syndromes (ACS) were included: 52 patients with Q - and 24 patients with non- Q wave myocardial infarction (Ml) who underwent emergency coronary artery bypass graft surgery (CABG) because of early post-infarction angina. Intravenous Corvitin 1% -100,0 ml...

Full description

Bibliographic Details
Main Authors: L. G. Gelis, N. A. Shibeko, E. A. Medvedeva, Yu. P. Ostrovsky, M. G. Kolyadko
Format: Article
Language:Russian
Published: InterMedservice 2012-06-01
Series:Евразийский Кардиологический Журнал
Subjects:
острый коронарный синдром
коронарное шунтирование
метаболическая защита
корвитин. reconstructive cardiac surgery in patients with acs
acute coronary syndrome
coronary artery bypass graft surgery
metabolic protection
corvitin
Online Access:https://www.heartj.asia/jour/article/view/5450

Internet

https://www.heartj.asia/jour/article/view/5450

Similar Items